← Questions/BEYOND THE SPINE
I have gut problems too. Is that part of it?
The short answer
Gut inflammation and AS travel together: spinal disease occurs in a large share of people with inflammatory bowel disease, joint symptoms often come first, and even people with AS and no gut symptoms frequently have subclinical gut inflammation. Immune cells appear to move between gut and joint, and the mix of gut bacteria differs in AS. Treatment has to work for both organs, which is why some drugs that help the spine are avoided when the bowel is involved.
5 papers behind this answer, best first
Clicking through to a study? How to read a paper is the ten-minute version.
Arthritis in inflammatory bowel disease.
Rheumatology (Oxford, England)
This review covers joint disease in inflammatory bowel disease: spinal involvement in anywhere from 6 to 62 percent of IBD patients depending on how it is looked for, joint symptoms often appearing before the bowel diagnosis, and treatments that have to work for both the gut and the spine. Shared genetics, a leaky gut barrier and immune cells travelling between gut and joint are the proposed links.
Comprehensive Phenotyping of Circulating T- and B-Cell Subsets in Patients with Ankylosing Spondylitis Associated with Crohn's Disease.
Cells
Comparing blood immune cells from people with ankylosing spondylitis plus Crohn's disease against those with either condition alone, the combined group had more regulatory T cells and a distinct pattern of memory T and B cells. It is a small pilot, but it suggests AS with gut disease is immunologically its own thing, not simply AS and Crohn's added together.
Gut microbiota and ankylosing spondylitis: current insights and future challenges
Microbial Cell
Comprehensive review of how gut bacterial imbalance disrupts the IL-23/IL-17 inflammatory pathway and weakens the intestinal barrier in AS. Identifies the lack of standardised methodology and large cohorts as the bottleneck for translating this into treatments.
HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation
Gut Microbes
Shows that HLA-B27, the gene most strongly linked to AS, reshapes which bacteria live in the gut and how the body handles certain amino acids, which in turn activates the inflammatory immune cells driving the disease. Suggests targeting the gut and these metabolic changes could become a real treatment route.
Experimental models of spondyloarthritis: Pathophysiological insights and translational challenges.
Journal of autoimmunity
This review takes stock of the mouse and rat models used to study spondyloarthritis and what each has taught us: the gut-joint connection, IL-23-driven inflammation where tendons meet bone, and the TNF pathways that became today's drugs. No single model captures the whole disease, which is one reason lab findings so often fail to translate, and the authors map what better models would need.
Plain-language guides on this from patient organisations
Reviewed sources written for patients. They cover the “what do I do” part that research papers can’t.
- NHS: Complications of AS ↗
NHS (UK)
- NASS: Living well with axial SpA (PDF guide) ↗
National Axial Spondyloarthritis Society (UK)